An observational study in IUGR, Thrombophilia and Pregnancy Complications, sponsored by Central Hospital, Nancy, France. Status unknown at 1 site in France. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-09-22.
Sponsored by Central Hospital, Nancy, France · Observational
This retrospective study aims to assess the input of thrombophilia screening in pregnant women with severe intra-uterine growth restricted babies.
437 studies on the registry are indexed under Pregnancy Complications; 119 are open to participants now.
This study's planned enrollment of 100 is below the median of 320 across 205 observational studies indexed under Pregnancy Complications.
Browse Pregnancy Complications studies →Central Hospital, Nancy, France is the lead sponsor of 778 studies on the registry; 183 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Biological: thrombophilia screening
In the IUGR group systematic thrombophilia screening had already been performed.
Rate of positive's thrombophilia screening
Time frame: 5 years
Plan to share: Undecided
No publications or documents are linked to this record.
This study is status unknown, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Central Hospital, Nancy, France